Ignite Creation Date:
2025-12-25 @ 2:43 AM
Ignite Modification Date:
2025-12-31 @ 3:26 PM
Study NCT ID:
NCT05359133
Status:
TERMINATED
Last Update Posted:
2025-02-20
First Post:
2022-04-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Randomized, Double-Blind, Placebo Controlled, Multicenter, Efficacy and Safety Trial of Single Cycle Tetrodotoxin in the Treatment of Chemotherapy Induced Neuropathic Pain
Sponsor:
Wex Pharmaceuticals Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-04-19
Start Date Type:
ACTUAL
Primary Completion Date:
2024-10-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-10-14
Completion Date Type:
ACTUAL
First Submit Date:
2022-04-25
First Submit QC Date:
None
Study First Post Date:
2022-05-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-18
Last Update Post Date:
2025-02-20
Last Update Post Date Type:
ACTUAL